Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Mid-range Performer
851.5000 3.90 (0.46%)
NSE Jun 16, 2026 15:31 PM
Volume: 560.4K
 

logo
Natco Pharma Ltd.
14 Dec 2015
851.50
0.46%
NATCO PHARMA LIMITED
Joindre Capital Services
Natco Pharma (NPL) is a vertically integrated and R&D; focused pharmaceutical company engaged in developing,manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). NPL's focus is primarily on niche therapeutic areas and complex products and it markets and distributes products in over...
ICICI Securities Limited upgraded Natco Pharma Ltd. to Hold with a price target of 1000.0 on 31 May, 2026.
More from Natco Pharma Ltd.
Recommended